Skip to content
10-K

Annual Report

GUIDED THERAPEUTICS INC GTHP

0001477932-26-001723

← back to feed
Filed
Mar 31, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 27, 2026 96.35M sh
Shares Diluted FY 2025 · Dec 31, 2025 78.41M sh
Shares Diluted FY 2025 · Dec 31, 2024 57.34M sh
Capex FY 2025 · Dec 31, 2025 $2K
Capex FY 2025 · Dec 31, 2024 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 −$1.07M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$1.12M
Stockholders Equity FY 2025 · Dec 31, 2025 −$6.01M
Stockholders Equity FY 2025 · Dec 31, 2024 −$4.89M
Stockholders Equity FY 2025 · Dec 31, 2023 −$3.81M
Current Liabilities FY 2025 · Dec 31, 2025 $6.64M
Current Liabilities FY 2025 · Dec 31, 2024 $6.16M
Total Liabilities FY 2025 · Dec 31, 2025 $7.33M
Total Liabilities FY 2025 · Dec 31, 2024 $6.27M
Current Assets FY 2025 · Dec 31, 2025 $605K
Current Assets FY 2025 · Dec 31, 2024 $1.2M
Total Assets FY 2025 · Dec 31, 2025 $1.32M
Total Assets FY 2025 · Dec 31, 2024 $1.38M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.04
Eps Diluted FY 2025 · Dec 31, 2024 −$0.05
Eps Basic FY 2025 · Dec 31, 2025 −$0.04
Eps Basic FY 2025 · Dec 31, 2024 −$0.05
Sga Expense FY 2025 · Dec 31, 2025 $2.31M
Sga Expense FY 2025 · Dec 31, 2024 $1.3M
Rd Expense FY 2025 · Dec 31, 2025 $469K
Rd Expense FY 2025 · Dec 31, 2024 $526K
Net Income FY 2025 · Dec 31, 2025 −$3.2M
Net Income FY 2025 · Dec 31, 2024 −$2.42M
Operating Income FY 2025 · Dec 31, 2025 −$2.37M
Operating Income FY 2025 · Dec 31, 2024 −$2.11M
Gross Profit FY 2025 · Dec 31, 2025 $571K
Gross Profit FY 2025 · Dec 31, 2024 $2K
Revenue FY 2025 · Dec 31, 2025 $767K
Revenue FY 2025 · Dec 31, 2024 $7K